KAPA Kairos Pharma, LTD.: institutional ownership and insider trading
15 funds reported holding $465K of Kairos Pharma, LTD. in their latest 13F filings; in Q2 2026 funds net bought $141K, with 7 new positions and 4 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
KAPA revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$1.39M, EPS -0.06
- Quarter ended Mar 31, 2026: revenue n/a, net income −$1.65M, EPS -0.08
- Quarter ended Dec 31, 2025: revenue n/a, net income −$1.37M, EPS -0.07
- Quarter ended Sep 30, 2025: revenue n/a, net income −$1.40M, EPS -0.07
Famous investors holding KAPA
- Ken Griffin (Citadel Advisors): $119K, 0.0% of the portfolio
Largest institutional holders of KAPA
- CITADEL ADVISORS LLC — $119K
- VANGUARD GROUP INC — $93.6K
- VANGUARD CAPITAL MANAGEMENT LLC — $89.0K
- Virtu Financial LLC — $31.0K
- GEODE CAPITAL MANAGEMENT, LLC — $30.3K
- VANGUARD FIDUCIARY TRUST CO — $24.5K
- SevenBridge Financial Group, LLC — $17.1K
- Aptus Capital Advisors, LLC — $17.0K
- JANE STREET GROUP, LLC — $12.9K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $11.2K
Recent KAPA insider trades
- Nov 25, 2024: Murali Ramachandran bought 200 shares ($318)
- Nov 22, 2024: Samuelson Doug bought 2,500 shares ($3.75K)
- Nov 20, 2024: Yu John S bought 4,000 shares ($5.76K)
Who owns the most KAPA stock?
The largest institutional holders of Kairos Pharma, LTD. in the latest 13F filings are CITADEL ADVISORS LLC ($119K), VANGUARD GROUP INC ($93.6K), VANGUARD CAPITAL MANAGEMENT LLC ($89.0K).
Are insiders buying or selling KAPA?
No open-market insider buys or sells of Kairos Pharma, LTD. were reported in the last 12 months.
Which famous investors own KAPA?
Ken Griffin.